Prostatic Size Reduction Following of Leuprorelin Acetate

Recruiting now

Conditions studied: Prostate Cancer Adenocarcinoma, Prostate Adenocarcinoma

In brief

To determine the possible reduction in prostate size following the administration of Leuprelin prior to the application of radiotherapy.

Key facts

Study ID

NCT06184464

Run by

Consorci Sanitari de Terrassa

People needed

40

Starts

2024-02-02

Expected to finish

2024-12-15

Last updated by the study team

2024-09-19

Who can join

Age: 18 and older, up to 95. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Man with Prostate positive biopsy. Able to Ssgned informed consent form. Need of hormonal treatment before start of radiotherapy

You may not qualify if…

• Patients With prostate size of less than 20 cc at diagnosis. Patients With Positive lymph nodes or metastatic prostate cancer disease on imaging studies.
• Patients with Previous pelvic radiation therapy.

Where it is running

• Hospital de Terrassa — Terrassa, Barcelona, Spain (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.